Viking Therapeutics (VKTX) Short Interest Ratio & Short Volume $65.98 +1.30 (+2.01%) (As of 07/26/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Viking Therapeutics Short Interest DataCurrent Short Interest15,100,000 sharesPrevious Short Interest16,830,000 sharesChange Vs. Previous Month-10.28%Dollar Volume Sold Short$896.64 millionShort Interest Ratio4.4 Days to CoverLast Record DateJuly 15, 2024Outstanding Shares110,270,000 sharesPercentage of Shares Shorted13.69%Today's Trading Volume9,139,143 sharesAverage Trading Volume4,850,698 sharesToday's Volume Vs. Average188% Short Selling Viking Therapeutics ? Sign up to receive the latest short interest report for Viking Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartVKTX Short Interest Over TimeVKTX Days to Cover Over TimeVKTX Percentage of Float Shorted Over Time Ad Crypto Swap Profits625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here Viking Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/15/202415,100,000 shares $896.64 million -10.3%N/A4.4 $59.38 6/30/202416,830,000 shares $892.16 million +32.8%N/A5 $53.01 6/15/202412,670,000 shares $659.09 million +2.9%N/A3.6 $52.02 5/31/202412,310,000 shares $766.42 million +1.2%N/A3.2 $62.26 5/15/202412,170,000 shares $949.38 million +0.5%N/A2 $78.01 4/30/202412,110,000 shares $963.71 million +8.6%N/A1.9 $79.58 Get the Latest News and Ratings for VKTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Viking Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 4/15/202411,150,000 shares $746.49 million +17.1%N/A1.8 $66.95 3/31/20249,520,000 shares $780.64 million -14.5%N/A1.5 $82.00 3/15/202411,140,000 shares $696.92 million -9.3%N/A1.8 $62.56 2/29/202412,280,000 shares $946.17 million +2.2%N/A2.2 $77.05 2/15/202412,020,000 shares $382.84 million -7.0%N/A3 $31.85 1/31/202412,920,000 shares $311.89 million -5.8%N/A4.6 $24.14 1/15/202413,710,000 shares $293.94 million +1.9%N/A5.3 $21.44 12/31/202313,460,000 shares $250.49 million -7.8%N/A5.3 $18.61 12/15/202314,600,000 shares $275.94 million -5.3%N/A5.9 $18.90 11/30/202315,420,000 shares $188.43 million -9.1%N/A6.4 $12.22 11/15/202316,970,000 shares $187.18 million +3.4%N/A8.5 $11.03 10/31/202316,420,000 shares $161.08 million +11.0%N/A8.6 $9.81 10/15/202314,800,000 shares $162.06 million +6.6%N/A7.7 $10.95 9/30/202313,890,000 shares $153.76 million +1.8%N/A7.8 $11.07 9/15/202313,640,000 shares $201.46 million +5.7%N/A6.6 $14.77 8/31/202312,910,000 shares $178.29 million -5.0%N/A5.6 $13.81 8/15/202313,590,000 shares $201.27 million +14.8%N/A5.5 $14.81 7/31/202311,840,000 shares $171.68 million -2.7%N/A4.2 $14.50 7/15/202312,170,000 shares $189.61 million +0.7%N/A4 $15.58 6/30/202312,090,000 shares $195.98 million +9.2%N/A3.6 $16.21 6/15/202311,070,000 shares $248.63 million -6.9%N/A2.2 $22.46 5/31/202311,890,000 shares $261.10 million -1.2%N/A2.5 $21.96 5/15/202312,030,000 shares $264.54 million +3.8%N/A2.5 $21.99 4/30/202311,590,000 shares $246.98 million +1.3%N/A2.6 $21.31 4/15/202311,440,000 shares $214.50 million +1.6%N/A2.7 $18.75 3/31/202311,260,000 shares $187.48 million +112.1%N/A2.9 $16.65 3/15/20235,310,000 shares $56.71 million +9.5%7.8%1.8 $10.68 2/28/20234,850,000 shares $53.40 million +4.1%7.1%1.3 $11.01 2/15/20234,660,000 shares $51.91 million +17.7%6.9%1.3 $11.14 1/31/20233,960,000 shares $34.69 million -33.2%5.9%1.1 $8.76 1/15/20235,930,000 shares $53.07 million +4.2%8.9%1.7 $8.95 12/30/20225,690,000 shares $53.49 million +201.1%8.4%1.7 $9.40 12/15/20221,890,000 shares $7.28 million +6.8%2.8%0.6 $3.85 11/30/20221,770,000 shares $7.17 million -1.7%2.6%2.3 $4.05“Generational Bull Run” Incoming (Ad)LIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.You can find out what they are by clicking here now. 11/15/20221,800,000 shares $8.05 million -5.3%2.7%2.4 $4.47 10/31/20221,900,000 shares $7.79 million +6.2%2.8%2.9 $4.10 10/15/20221,790,000 shares $5.85 million -4.8%2.7%2.6 $3.27 9/30/20221,880,000 shares $5.11 million -2.6%2.8%3 $2.72 9/15/20221,930,000 shares $6.41 million -4.5%2.8%2.2 $3.32 8/31/20222,020,000 shares $6.42 million -3.4%3.0%2.1 $3.18 8/15/20222,090,000 shares $8.13 million -3.7%3.1%1.9 $3.89 7/31/20222,170,000 shares $0.00 -11.4%3.2%1.9 $0.00 7/15/20222,450,000 shares $9.07 million -9.6%3.6%2.2 $3.70 6/30/20222,710,000 shares $7.83 million -41.1%3.9%2.4 $2.89 6/15/20224,600,000 shares $9.98 million -1.9%6.7%4.4 $2.17 5/31/20224,690,000 shares $10.41 million +4.5%6.8%4.9 $2.22 5/15/20224,490,000 shares $10.46 million +16.3%6.5%4.8 $2.33 4/30/20223,860,000 shares $9.19 million +4.3%5.6%3.9 $2.38 4/15/20223,700,000 shares $10.21 million +3.9%5.4%3.4 $2.76 3/31/20223,560,000 shares $10.68 million -20.2%5.1%3.2 $3.00 3/15/20224,460,000 shares $13.51 million +2.5%6.4%3.9 $3.03 2/28/20224,350,000 shares $14.57 million +4.8%6.2%4.1 $3.35 2/15/20224,150,000 shares $15.69 million -4.2%5.9%3.8 $3.78 1/31/20224,330,000 shares $16.06 million +19.0%6.2%4.5 $3.71 1/15/20223,640,000 shares $15.43 million -0.6%5.2%4 $4.24 12/31/20213,660,000 shares $16.84 million -12.0%5.3%5.1 $4.60 12/15/20214,160,000 shares $20.09 million -15.8%5.9%6.1 $4.83 11/30/20214,940,000 shares $26.23 million +3.4%7.0%8 $5.31 11/15/20214,780,000 shares $28.73 million -4.0%6.8%7.7 $6.01 10/29/20214,980,000 shares $28.98 million +4.8%7.1%8 $5.82 10/15/20214,750,000 shares $28.55 million -6.3%6.8%7.8 $6.01 9/30/20215,070,000 shares $31.84 million -13.5%7.2%8 $6.28 9/15/20215,860,000 shares $38.03 million -8.0%8.3%8.4 $6.49 8/31/20216,370,000 shares $42.11 million -13.7%9.1%7.9 $6.61 8/13/20217,380,000 shares $43.62 million -9.0%10.5%8.4 $5.91 7/30/20218,110,000 shares $49.88 million +2.8%11.6%9 $6.15 7/15/20217,890,000 shares $46.08 million -3.1%11.3%8.4 $5.84 6/30/20218,140,000 shares $48.76 million -17.8%11.6%8.3 $5.99 6/15/20219,900,000 shares $59.70 million -2.5%14.1%10.1 $6.03 5/28/202110,150,000 shares $53.19 million -5.8%14.5%11 $5.24 5/14/202110,770,000 shares $63.76 million +1.7%15.4%11.2 $5.92 4/30/202110,590,000 shares $66.29 million -4.6%15.2%9.5 $6.26 4/15/202111,100,000 shares $66.60 million +10.5%16.1%8.2 $6.00 3/31/202110,050,000 shares $60.90 million +18.0%15.5%7.1 $6.06 3/15/20218,520,000 shares $57.51 million +1.2%13.1%5.6 $6.75 2/26/20218,420,000 shares $57.93 million +1.7%13.0%5.5 $6.88 2/12/20218,280,000 shares $72.12 million -2.2%12.7%5.4 $8.71 1/29/20218,470,000 shares $63.69 million -3.5%13.1%5.8 $7.52 1/15/20218,780,000 shares $58.47 million -3.3%13.6%6.7 $6.66 12/31/20209,080,000 shares $53.03 million +3.1%14.0%7.4 $5.84 12/15/20208,810,000 shares $59.12 million -11.6%13.5%7.6 $6.71 11/30/20209,960,000 shares $66.53 million -7.0%15.3%8.4 $6.68 10/30/202010,140,000 shares $56.58 million -2.5%15.6%8.4 $5.58 10/15/202010,400,000 shares $60.89 million -7.1%16.0%8.5 $5.86“Generational Bull Run” Incoming (Ad)LIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.You can find out what they are by clicking here now. 9/30/202011,200,000 shares $65.18 million +19.9%17.3%8.9 $5.82 9/15/20209,340,000 shares $58.38 million +7.1%14.4%7.1 $6.25 8/31/20208,720,000 shares $58.34 million -0.1%13.4%6.6 $6.69 8/14/20208,730,000 shares $64.25 million -17.6%12.3%6.5 $7.36 7/31/202010,590,000 shares $74.34 million +6.3%14.9%7.2 $7.02 7/15/20209,960,000 shares $68.23 million -16.4%14.1%6.4 $6.85 6/30/202011,920,000 shares $85.94 million +8.6%16.9%7.3 $7.21 6/15/202010,980,000 shares $82.57 million -2.1%15.5%6.7 $7.52 5/29/202011,210,000 shares $80.15 million -8.5%15.9%6.5 $7.15 5/15/202012,250,000 shares $86.98 million -1.5%17.3%7 $7.10 4/30/202012,440,000 shares $71.65 million -8.7%17.6%7.8 $5.76 4/15/202013,620,000 shares $71.78 million -7.7%19.3%9.3 $5.27 3/31/202014,760,000 shares $69.08 million +0.1%20.9%10.8 $4.68 3/13/202014,749,400 shares $74.48 million -11.5%23.3%10.4 $5.05 2/28/202016,660,000 shares $67.47 million +11.1%26.3%14.5 $4.05 2/14/202014,990,000 shares $83.94 million -2.8%23.4%13.1 $5.60 1/31/202015,420,000 shares $96.07 million -6.1%24.0%12.5 $6.23 1/15/202016,420,000 shares $109.69 million +10.2%25.6%12.2 $6.68 12/31/201914,900,000 shares $98.19 million -5.8%23.2%11.6 $6.59 VKTX Short Interest - Frequently Asked Questions What is Viking Therapeutics' current short interest? Short interest is the volume of Viking Therapeutics shares that have been sold short but have not yet been covered or closed out. As of July 15th, investors have sold 15,100,000 shares of VKTX short. Learn More on Viking Therapeutics' current short interest. What is a good short interest ratio for Viking Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. VKTX shares currently have a short interest ratio of 4.0. Learn More on Viking Therapeutics's short interest ratio. Which institutional investors are shorting Viking Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Viking Therapeutics: Concourse Financial Group Securities Inc., Walleye Trading LLC, Ikarian Capital LLC, Jane Street Group LLC, PEAK6 Investments LLC, HAP Trading LLC, and XR Securities LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Viking Therapeutics' short interest increasing or decreasing? Viking Therapeutics saw a decline in short interest during the month of July. As of July 15th, there was short interest totaling 15,100,000 shares, a decline of 10.3% from the previous total of 16,830,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Viking Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Viking Therapeutics: Prothena Co. plc (8.87%), Puma Biotechnology, Inc. (10.94%), Marinus Pharmaceuticals, Inc. (4.92%), Teva Pharmaceutical Industries Limited (1.56%), Genmab A/S (0.34%), Royalty Pharma plc (4.29%), BioMarin Pharmaceutical Inc. (3.93%), BeiGene, Ltd. (1.67%), United Therapeutics Co. (9.57%), Viatris Inc. (3.64%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.13 billion), Royal Caribbean Cruises Ltd. ($2.77 billion), Moderna, Inc. ($2.76 billion), Coinbase Global, Inc. ($2.36 billion), Rivian Automotive, Inc. ($2.22 billion), Paychex, Inc. ($2.02 billion), Tractor Supply ($1.81 billion), Enphase Energy, Inc. ($1.65 billion), Chesapeake Energy Co. ($1.62 billion), and Lululemon Athletica Inc. ($1.58 billion). View all of the most shorted stocks. What does it mean to sell short Viking Therapeutics stock? Short selling VKTX is an investing strategy that aims to generate trading profit from Viking Therapeutics as its price is falling. VKTX shares are trading up $1.30 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Viking Therapeutics? A short squeeze for Viking Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of VKTX, which in turn drives the price of the stock up even further. How often is Viking Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including VKTX, twice per month. The most recent reporting period available is July, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Prothena Short Squeeze Puma Biotechnology Short Squeeze Marinus Pharmaceuticals Short Squeeze Teva Pharmaceutical Industries Short Squeeze Genmab A/S Short Squeeze Royalty Pharma Short Squeeze BioMarin Pharmaceutical Short Squeeze BeiGene Short Squeeze United Therapeutics Short Squeeze Viatris Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:VKTX) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredFormer Hedge Fund Manager Issues Crash PredictionOur No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock (June 12) This $2 trillion D.C. shock i...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Viking Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Viking Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.